Versant Capital Management, Inc Emergent Bio Solutions Inc. Transaction History

Versant Capital Management, Inc

$454 Million
Q4 2024

A detailed history of Versant Capital Management, Inc transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 166 shares of EBS stock, worth $1,935. This represents 0.0% of its overall portfolio holdings.

Number of Shares

166

Previous 166 -0.0%

Holding current value

$1,935

Previous $1,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 08, 2024	SELL	$1.82 - $3.16 $258 - $448	-142 Reduced 46.1%	166 $0
Q2 2023 Jul 10, 2023	SELL	$7.35 - $13.21 $499 - $898	-68 Reduced 18.09%	308 $2,000
Q1 2023 Apr 10, 2023	SELL	$7.79 - $16.29 $2,181 - $4,561	-280 Reduced 42.68%	376 $3,000
Q4 2022 Jan 25, 2023	BUY	$11.0 - $21.45 $5,533 - $10,789	503 Added 328.76%	656 $0
Q3 2022 Dec 30, 2022	BUY	$20.09 - $35.8 $100 - $179	5 Added 3.38%	153 $3,000
Q2 2022 Aug 02, 2022	SELL	$27.42 - $43.63 $575 - $916	-21 Reduced 12.43%	148 $5,000
Q1 2022 Apr 29, 2022	BUY	$36.48 - $52.22 $6,165 - $8,825	169 New	169 $7,000
Q3 2020 Nov 02, 2020	SELL	$81.91 - $134.94 $33,910 - $55,865	-414 Closed	0 $0
Q2 2020 Jul 16, 2020	BUY	$54.33 - $89.52 $271 - $447	5 Added 1.22%	414 $32,000
Q1 2020 Apr 17, 2020	BUY	$49.34 - $68.76 $6,463 - $9,007	131 Added 47.12%	409 $23,000
Q4 2019 Jan 28, 2020	BUY	$51.21 - $59.06 $2,355 - $2,716	46 Added 19.83%	278 $14,000
Q3 2019 Oct 18, 2019	BUY	$40.6 - $57.2 $4,750 - $6,692	117 Added 101.74%	232 $12,000
Q2 2019 Jul 16, 2019	SELL	$39.92 - $53.86 $6,746 - $9,102	-169 Reduced 59.51%	115 $5,000
Q1 2019 Apr 23, 2019	BUY	$48.23 - $66.16 $13,022 - $17,863	270 Added 1928.57%	284 $14,000
Q1 2019 Apr 23, 2019	SELL	$48.23 - $66.16 $12,877 - $17,664	-267 Reduced 95.02%	14 $14,000
Q4 2018 Jan 29, 2019	SELL	$55.63 - $73.24 $111 - $146	-2 Reduced 0.71%	281 $16,000
Q3 2018 Oct 15, 2018	SELL	$52.05 - $66.51 $2,290 - $2,926	-44 Reduced 13.46%	283 $18,000
Q1 2018 Apr 19, 2018	SELL	$44.44 - $54.39 $1,066 - $1,305	-24 Reduced 6.84%	327 $17,000
Q4 2017 Apr 19, 2018	BUY	$37.77 - $47.75 $151 - $191	4 Added 1.15%	351 $16,000
Q3 2017 Apr 23, 2018	BUY	$34.14 - $40.45 $580 - $687	17 Added 5.15%	347 $14,000
Q2 2017 Apr 23, 2018	BUY	N/A	74 Added 28.91%	330 $11,000
Q1 2017 Apr 23, 2018	BUY	N/A	9 Added 3.64%	256 $7,000
Q4 2016 Apr 23, 2018	SELL	N/A	-23 Reduced 8.52%	247 $8,000
Q2 2016 Apr 23, 2018	SELL	N/A	-2 Reduced 0.74%	270 $7,000
Q1 2016 Apr 23, 2018	SELL	N/A	-42 Reduced 13.38%	272 $9,000
Q4 2015 Apr 23, 2018	BUY	N/A	314	314 $12,000

Others Institutions Holding EBS

# of Institutions

157

Shares Held

33.7M

Call Options Held

453K

Put Options Held

931K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $581M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.

Account

Versant Capital Management, Inc Emergent Bio Solutions Inc. Transaction History